Vascular Concepts, a cardiovascular technology, has received the 2017 Asia-Pacific Coronary Care-Drug Eluting Stent Growth Excellence Leadership Award in March, 2017 in London.

Frost & Sullivan presented this award in recognition of companies that demonstrate an outstanding performance in the Asia-Pacific market in cardiac care. It also highlights excellence in patients’ safety and performance. It validates the company’s quality-focused approach to product manufacturing in Germany, which ensures product integrity at with a focus on a patient-centric approach to treat cardiovascular diseases(CVDs).

The Rs.150 crore Bengaluru-based company set up in 1998 designs, develops, manufactures and markets endovascular devices that aid less invasive therapy. It offers its products for the treatment of arterial diseases, which include coronary artery and peripheral vascular diseases. It is the only Indian company with an extensive patent portfolio exceeding 35 US/EU technology patents covering design and manufacturing of various peripheral vascular products. All certifications are granted by BSI (British Standards Certifications).

Over 500,000 coronary stents and 25,000 congenital heart defect devices have been implanted by the company till date. The cardiac stents have undergone continuous evolution from the basic bare metal stents (BMS) to the advanced drug eluting stents (DES). Further, it  pioneered the extra-long stents now used in the drug eluting category. Its upcoming aortic valve or transcatheter aortic valve implant product is another revolutionary solution in the field of angioplasty, which is undergoing clinical studies, said F&S.

The company’s Heart Insure Programme is a patient-welfare campaign that offers patients post-procedure health guidance and lifestyle management tips provided through regular follow up phone calls by a dedicated team. It  conducts periodic patient awareness camps where the treated patients undergo basic cardiac investigations and consultations from their cardiologists. The patient-centric approach has motivated cardiologists to join and recommend the beneficial service by Vascular Concepts to their patients as a pro-active way to promote wellness.

Earlier Vascular Concepts won the Alexandria-Frost & Sullivan Award for Excellence in Indian Healthcare, under the Indian Medical Devices Company of The Year’ in 2010 and 2011.

“Whilst we understand that there are many aspects to a business' success, corporate leaders are at the forefront of medical device industry development, through trying economic times, competitively pricing their products, and developing strategies to attract and retain customers. Overcoming adversity is the key to good business leadership. This award is an incredible achievement for our company that is working relentlessly to help the business prosper, despite operating in an increasingly tough climate,” said Swaminathan Jayaraman, CMD, Vascular Concepts.